|
CN105277628A
|
|
Method for determining ramelteon and impurities thereof through high-performance liquid chromatography separation
|
|
CN105085481A
|
|
Recrystallization method of rabeprazole sodium
|
|
CN104020239A
|
|
Method for separating and determining rebeprazole sodium and impurities thereof through high performance liquid chromatography (HPLC)
|
|
CN103919737A
|
|
Rabeprazole sodium freeze-dried powder injection and preparation method thereof
|
|
CN105012253A
|
|
Pramipexole dihydrochloride orally disintegrating tablets and preparation method for same
|
|
CN104777241A
|
|
Method used for detecting concentration of rivaroxaban in blood plasma
|
|
CN104744355A
|
|
Method for preparing torasemide and derivative thereof
|
|
CN104546746A
|
|
Ramelteon tablets and preparation process thereof
|
|
CN104546696A
|
|
S-(-)-nadifloxacin-L-arginine single-dose eye drop and preparation process thereof
|
|
CN104414968A
|
|
Levofloxacin single-dose eye drops and preparation method thereof
|
|
CN104341360A
|
|
A rufinamide preparing method
|
|
CN104323986A
|
|
Phloroglucinol injection and preparation method thereof
|
|
CN103364498A
|
|
Method for detecting concentration of metacavir and metabolites thereof in biological sample
|
|
CN103860520A
|
|
Moxifloxacin capsules, and preparation method thereof
|
|
CN103864669A
|
|
Novel crystal form of Mitiglinide calcium and preparation method thereof
|
|
CN103869033A
|
|
Liquid chromatography method for separating and determining moxifloxacin hydrochloride and impurity thereof
|
|
CN103373962A
|
|
Method for preparing celecoxib III crystal form
|
|
CN103364512A
|
|
Method for detecting concentration of levodopa methyl ester and levodopa in blood plasma
|
|
CN103360448A
|
|
Single crystal form of metacavir ethanol solvent compound and preparation method thereof
|
|
CN103226142A
|
|
Method for detecting leucogen concentration in blood plasma
|
